| Website | catalystbioscienc... |
| Category | BioTech |
| Phone | (650) 871-0761 |
| info@catbio.com | |
| Employees | 50 |
| Founded | 2003 |
| Description | Healthcare Biotechnology |
| TOTAL | $70M |
| FUNDING TOTAL | $70M |
| Series B, 2/06 Morgenthaler Ventures HealthCare Ventures Sofinnova Ventures Burrill & Company RCT BioVentures Novartis Venture Fund | $30M |
| Series C, 12/08 Johnson & Johnson Development Corporation Morgenthaler Ventures HealthCare Ventures Sofinnova Ventures Essex Woodlands Health Ventures Novartis Venture Funds Burrill & Company | $40M |
Catalyst Biosciences is a drug discovery and development company that is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation.
The Company’s product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alterase™ therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs.
